Kyiv City Clinical Oncological Center
About Kyiv City Clinical Oncological Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
13
Janssen Research & Development, LLC
5
Merck Sharp & Dohme LLC
4
Incyte Corporation
3
BeyondSpring Pharmaceuticals Inc.
2
Eisai Limited
2
Loxo Oncology, Inc.
2
MacroGenics
2
Pfizer
2
AEterna Zentaris
1
Agenus Inc.
1
Clinical Trials at Kyiv City Clinical Oncological Center
During the past decade, Kyiv City Clinical Oncological Center conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 13 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 7 clinical trials were completed. i.e. 38.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures
2008-08-01
2009-01-09
Terminated
21
Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy
2008-06-01
Terminated
10
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
2011-04-01
2013-06-01
Terminated
140
E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer
2011-11-01
2013-07-01
Terminated
7
Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
2011-11-01
2016-09-21
Completed
758
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
2012-01-20
2016-03-30
Completed
501
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kyiv City Clinical Oncological Center" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Janssen Research & Development, LLC" with 5 trials
sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Incyte Corporation" with 3 trials sponsored and "BeyondSpring Pharmaceuticals Inc."
with 3 trials sponsored. Other sponsors include 18 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kyiv City Clinical Oncological Center"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Kyiv City Clinical Oncological Center
According to Clinical.Site data, the most researched conditions in "Kyiv City Clinical Oncological Center" are
"Carcinoma, Non-Small-Cell Lung" (4 trials), "Non-Small Cell Lung Cancer" (4 trials), "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Kyiv City Clinical Oncological Center" in a lesser frequency.
Clinical Trials Intervention Types at Kyiv City Clinical Oncological Center
Most popular intervention types in "Kyiv City Clinical Oncological Center" are "Drug" (44 trials), "Biological" (6 trials), "Other" (5 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "Cisplatin" (9 trials), "Pembrolizumab" (7 trials), "Carboplatin" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Kyiv City Clinical Oncological Center
The vast majority of trials in "Kyiv City Clinical Oncological Center" are
43 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Kyiv City Clinical Oncological Center
Currently, there are NaN active trials in "Kyiv City Clinical Oncological Center".
undefined are not yet recruiting,
13 are recruiting,
13 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in Kyiv City Clinical Oncological Center,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Kyiv City Clinical Oncological Center, 4 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 36 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Kyiv City Clinical Oncological Center
Kyiv City Clinical Oncological Center has several departments that took part in Clinical trials: "Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa)" - 18 trials, "Kyiv Regional Oncological Dispensary" - 8 trials, "Communal institution of the Kyiv Regional Council "Kyiv Regional Clinical Oncology Dispensary"" - 8 trials, "Clinical Diagnostic Center - Pediatric Cardiovascular and ANES and Intensive Care Department - Site 4103" - 2 trials
Departments List
Name
City
Trials